Rchr
J-GLOBAL ID:200901098266421778   Update date: May. 14, 2024

Takahashi Shinichiro

タカハシ シンイチロウ | Takahashi Shinichiro
Affiliation and department:
Job title: Professor
Research field  (1): Other
Research keywords  (4): 転写制御 ,  シグナル伝達 ,  白血病 ,  血液
Research theme for competitive and other funds  (18):
  • 2023 - 2027 糖転移酵素GnT-IIIによるがんの薬剤耐性の制御とその分子機序の解明
  • 2023 - 2026 一般検診の基本的データを用いた人工知能による膵癌マススクリーニング法の確立
  • 2021 - 2026 Establishment of efficient leukemia differentiation therapy, and biomarker, through various inhibitors
  • 2022 - 2025 Elucidation of molecular mechanism for IgG levels regulated by L-fucose
  • 2017 - 2021 Clarifying the pathogenesis of hematological malignancies and development of diagnostic markers through analysing PU.1 target genes
Show all
Papers (95):
  • Souma Suzuki, Susumu Suzuki, Yuri Sato-Nagaoka, Chisaki Ito, Shinichiro Takahashi. Identification of triciribine as a novel myeloid cell differentiation inducer. PLOS ONE. 2024
  • Susumu Suzuki, Jianwei Liu, Yuri Sato, Rikuto Miyake, Souma Suzuki, Yoko Okitsu, Tomohiko Fukuda, Tomoya Isaji, Jianguo Gu, Shinichiro Takahashi. Fucosylation inhibitor 6-alkynylfucose enhances the ATRA-induced differentiation effect on acute promyelocytic leukemia cells. Biochemical and Biophysical Research Communications. 2024
  • Jianwei Liu, Tomoya Isaji, Sachiko Komatsu, Yuhan Sun, Xing Xu, Tomohiko Fukuda, Tsutomu Fujimura, Shinichiro Takahashi, Jianguo Gu. BRCC36 associates with FLT3-ITD to regulate its protein stability and intracellular signaling in acute myeloid leukemia. Cancer Science. 2024
  • Ririka MIURA, Rikei KOZAKAI, Susumu SUZUKI, Shinichiro TAKAHASHI. Analysis of Incident/Accident Reports in the Department of Clinical Laboratory at Tohoku Medical and Pharmaceutical University Hospital: Effect of ISO 15189 Implementation on Medical Safety. Laboratory Medicine International. 2024
  • Jun Nomura, Masafumi Seki, Syori Abe, Tadahiro Kobayashi, Yoko Okitsu, Noriko Fukuhara, Shinichiro Takahashi, Hideo Harigae, Junichi Kameoka. Progression of hemolysis in a patient with hereditary spherocytosis after the second dose of COVID-19 mRNA vaccine. Human vaccines & immunotherapeutics. 2023. 19. 1. 2165381-2165381
more...
MISC (61):
Books (4):
  • 婦人科がん薬物療法パーフェクトガイド
    診断と治療社 2021 ISBN:9784787824806
  • スタンダード検査血液学
    医歯薬出版 2021 ISBN:9784263226919
  • Trends in Signal Transduction Research, Chapter 8, FLT3 Signal Transduction and Leukemia (p191-204)
    Nova Science Publishers 2007 ISBN:1600213758
  • PU.1, a versatile transcription factor and a suppressor of myeloid leukemia, Myeloid Leukemia/ Book 1 (Editor: Steffen Koschmieder)
    Intech Open Access Publisher
Education (2):
  • - 2000 Tohoku University
  • - 1994 Hirosaki University School of Medicine Medicine
Work history (6):
  • 2017/02 - 現在 Tohoku Medical and Pharmaceutical University
  • 2016/04 - 2017/02 Tohoku Medical and Pharmaceutical University Clinical Laboratory Department, Faculty of Medicine Professor
  • 2007/04 - 2016/03 Kitasato University Division of Hematology, School of Allied Health Sciences
  • 2003/09 - 2007/03 Tohoku University Hospital Department of Clinical Laboratory
  • 2001/06 - 2003/08 Mt. Sinai University, USA Division of Hematology, School of Medicine
Show all
Committee career (9):
  • 2022/04 - 現在 医療関連サービス振興会 衛生検査所業務・調査指導員
  • 2020/07 - 現在 日本臨床検査医学会 利益相反委員会委員
  • 2019/12 - 現在 日本医療検査科学会 血液検査機器技術委員会委員
  • 2018/04 - 現在 日本検査血液学会 評議員
  • 2017/11 - 現在 日本臨床検査医学会 評議員
Show all
Awards (4):
  • 2012/01 - 神奈川難病研究財団 神奈川難病研究財団賞
  • 2006/12 - 公益信託 日本白血病研究基金 若手奨励研究賞
  • 2003/12 - American Society of Hematology Travel Award
  • 2001/03 - Tohoku University School of Medicine Silver Prize
Association Membership(s) (7):
日本臨床検査専門医会 ,  JAPANESE SOCIETY OF LABORATORY MEDICINE ,  日本輸血細胞治療学会 ,  日本検査血液学会 ,  日本内科学会 ,  日本血液学会 ,  日本医療検査科学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page